慢性恶心吐综合征和对生活质量的影响
F A Félix-Téllez1, J A Velarde-Ruiz Velasco2, J M Aldana-Ledesma1
1Servicio de Gastroenterología, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.
Revista de gastroenterologia de Mexico (English)
|October 10, 2024
概括
慢性恶心吐综合征显著影响成人的生活质量和工作生产力. 这种肠-大脑相互作用障碍导致更多的医疗访问,但不会增加成本.
科学领域:
- 胃肠病学 胃肠病学
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
背景情况:
- 慢性恶心吐综合征 (CNVS) 是一种普遍存在的肠脑相互作用障碍,影响着劳动年龄人口.
- 了解其对日常生活和经济的影响对于有针对性的干预至关重要.
研究的目的:
- 评估 CNVS 与生活质量之间的关联.
- 评估CNVS对工作场所绩效和社会经济因素的影响.
主要方法:
- 对1000名墨西哥患者进行了一项横截面研究.
- 患者被分类为 CNVS 或其他肠-大脑相互作用障碍.
- 后勤回归分析了生活质量,生产力,医疗咨询和费用.
主要成果:
- 在10.3%的患有肠-大脑相互作用障碍的患者中,诊断出CNVS.
- CNVS与生活质量下降有显著的相关性,包括疼痛,焦虑和抑郁.
- 这种综合症与工作场所存在率和缺勤率的增加有关.
结论:
- CNVS对生活质量产生负面影响,可能是由于其症状或同时出现的焦虑和抑郁.
- 调查结果强调了CNVS对个人和劳动力的巨大负担.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
179
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
179
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
151
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
151
Pathophysiology of Vomiting
332
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
332
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
203
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
203
Bulimia Nervosa
55
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
55
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
230
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
230


